[Shulman syndrome, diffuse eosinophilic fasciitis].
Hara
M
M
Institute of Rheumatology, Tokyo Women's Medical University.
D015551:Autoimmunity; D003094:Collagen / Q000378:metabolism; D055513:Connective Tissue Growth Factor; D003937:Diagnosis, Differential; D004802:Eosinophilia / Q000209:etiology / Q000503:physiopathology; D005208:Fasciitis / Q000209:etiology / Q000503:physiopathology; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D017874:Immediate-Early Proteins / Q000378:metabolism; D036341:Intercellular Signaling Peptides and Proteins; D008193:Lyme Disease / Q000150:complications; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis; D013577:Syndrome
C526317:CCN2 protein, human; D006133:Growth Substances; D017874:Immediate-Early Proteins; D036341:Intercellular Signaling Peptides and Proteins; D055513:Connective Tissue Growth Factor; D003094:Collagen; D011239:Prednisolone